Evaluation of Predictor Factors of Non-Diabetic Nephropathy in Diabetic Patient’s Biopsy Specimen in Labbafinejad Hospital
Student Research in Translational Medicine,
Vol. 4 (2022),
28 November 2022
,
Page 1-6
https://doi.org/10.22037/srtm.v7.37194
Abstract
Background and Aim: Nephropathy is one of the major complications in diabetic patients that causes high mortality worldwide. In diabetic patients, differentiating non-diabetic nephropathy from diabetic nephropathy is clinically essential in treating patients. The present study aimed to examine clinical, laboratory, demographic variables and their relationship with the type of non-diabetic nephropathy in diabetic patients.
Methods: Clinical, demographic and laboratory data of 104 diabetic patients who underwent renal biopsy in Labbafinejad Hospital in Tehran in 2009-2010 were assessed. Patients were categorized into two groups based on the type of nephropathy (whether diabetic or non-diabetic). The recorded data were statistically compared between the two groups at the time of kidney biopsy and six months later.
Results: In this study, 104 patients were studied. The mean age of patients was 57.2 ± 13.4 years, and 50% of patients were male. Shorter duration of diabetes, no insulin use, renal failure, higher mean arterial pressure, smaller kidneys, lack of diabetic retinopathy, lower GFR and higher serum creatinine in patients with diabetic nephropathy were identical with non-diabetic nephropathy group (in all cases) (P < 0.05).
Conclusion: The need for kidney biopsy in diabetic patients can be determined with acceptable accuracy using the mentioned demographic, clinical, imaging and laboratory data. This study showed that the six-month GFR index could be used as a prognostic marker in patients.
- Diabetic nephropathy
- ; non-diabetic nephropathy
- Type 2 diabetes
- Kidney biopsy
How to Cite
References
Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nature Reviews Nephrology. 2018 Jun;14(6):361-77.
Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, De Boer IH. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. Jama. 2016 Aug 9;316(6):602-10.
Sepahi MA, Lakkakula BV, Kellner SJ, Valizadeh R. Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths. Journal of Nephropathology. 2020 Jan 1;9(1).
E. Espinel, I. Agraz, Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Serón D. Renal biopsy in type 2 diabetic patients. Journal of Clinical Medicine. 2015 May;4(5):998-1009.
Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Serón D. Renal biopsy in type 2 diabetic patients. Journal of Clinical Medicine. 2015 May;4(5):998-1009.
Yamazaki T, Mimura I, Tanaka T, Nangaku M. Treatment of diabetic kidney disease: current and future. Diabetes & Metabolism Journal. 2021 Jan 22;45(1):11-26.
Suarez ML, Thomas DB, Barisoni L, Fornoni A. Diabetic nephropathy: is it time yet for routine kidney biopsy?. World journal of diabetes. 2013 Dec 15;4(6):245.
Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G, D'Arrigo G, Gesualdo L, ERA-EDTA Immunonephrology Working Group. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrology Dialysis Transplantation. 2017 Jan 1;32(1):97-110.
Jewell NP. Statistics for epidemiology. Chapman and hall/CRC; 2003 Aug 26.
Ottenbacher KJ, Ottenbacher HR, Tooth L, Ostir GV. A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. Journal of clinical epidemiology. 2004 Nov 1;57(11):1147-52.
United States Renal Data System. Chapter 1: CKD in the General Population. 2015 USRDS annual data report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015.
Centers for Disease Control and Prevention. Deaths and Mortality. Available at http://www.cdc.gov/nchs/fastats/deaths.htm. May 3, 2017; Accessed: May 1, 2019.
Zhou J, Chen X, Xie Y, Li J, Yamanaka N, Tong X. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases. Nephrology Dialysis Transplantation. 2008 Jun 1;23(6):1940-5.
Du Y, Heidemann C, Rosario AS, Buttery A, Paprott R, Neuhauser H, Riedel T, Icks A, Scheidt-Nave C. Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997–1999 and 2008–2011. BMJ Open Diabetes Research and Care. 2015 Nov 1;3(1):e000135.
Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. Journal of nephropharmacology. 2016;5(1):49.
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.
Zhou J, Chen X, Xie Y, Li J, Yamanaka N, Tong X. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2008;23(6):1940-5.
Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–8.
Maric-Bilkan C. Sex differences in diabetic kidney disease. InMayo Clinic Proceedings 2020 Mar 1 (Vol. 95, No. 3, pp. 587-599). Elsevier
Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012 Dec 12. 308(22):2349-60.
Bermejo S, Soler MJ, Gimeno J, Barrios C, Rodríguez E, Mojal S, Pascual J. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy. Nefrologia. 2016 Sep-Oct;36(5):535-544.
Ayodele OE, Alebiosu CO, Salako BL. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. Journal of the National Medical association. 2004 Nov;96(11):1445.
Shen X, Zhang Z, Zhang X, Zhao J, Zhou X, Xu Q, Shang H, Dong J, Liao L. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. Lipids in Health and Disease. 2016 Dec;15(1):1-1.
- Abstract Viewed: 187 times
- PDF Downloaded: 150 times
